Business Context and Reporting Period
This Form 8-K is filed by Renatus Tactical Acquisition Corp I, a Cayman Islands-based special purpose acquisition company (SPAC), for the reporting period of June 5, 2026. The filing addresses corporate governance changes and regulatory compliance status regarding Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and regulatory compliance rather than financial performance.
Material Changes
- Director Resignation: Mr. Matan Fattal resigned as a director and member of the Audit, Compensation, and Nominating and Corporate Governance Committees, effective June 5, 2026. The resignation was not due to any dispute with the Company.
- Board Composition: Following the resignation, the Board consists of two independent directors, two non-independent directors, and one vacant seat.
- Nasdaq Noncompliance: The Company notified Nasdaq of temporary noncompliance with Listing Rule 5605(c)(2)(A) (Audit Committee size) and Rule 5605(b) (majority of independent directors).
Outlook, Risks, and Management Commentary
- Remediation Plan: The Company intends to utilize the cure periods provided under Nasdaq Listing Rules 5605(c)(4)(B) and 5605(b)(1)(A) to regain compliance.
- Recruitment: Management is actively searching for a new independent director to fill the vacancy and restore the Audit Committee to the required minimum of three members.
- Risk: Continued failure to cure the noncompliance within the specified cure periods could result in delisting from The Nasdaq Global Market.
Investor Verification Checklist
- Verify the timeline for appointing a new independent director to ensure compliance with Nasdaq cure periods.
- Confirm the current status of the Audit Committee and whether it can function effectively with two members during the transition.
- Monitor subsequent filings for updates on the search for a replacement director and any potential impact on the SPAC's business combination timeline.